WBH Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
WBH Advisory's XBI Position: Q3 2026 in Review
WBH Advisory held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 2,080 shares worth $328K. The position accounts for 0.02% of the portfolio, ranked #307.
WBH Advisory first reported a position in XBI in Q4 2020 and has held it in 12 quarters since. The position peaked at $329K in Q2 2026. 952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- WBH Advisory held 2,080 shares of State Street SPDR S&P Biotech ETF worth $328K as of Q3 2026.
- WBH Advisory left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.02% of WBH Advisory's portfolio in Q3 2026, its #307 holding.
- WBH Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 12 quarters since.
- WBH Advisory's State Street SPDR S&P Biotech ETF position peaked at $329K in Q2 2026.
- 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on WBH Advisory's 13F filing for Q3 2026, filed 5 Nov 2026.